Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 3-phosphoinositide dependent protein kinase 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1461 | 1 | 1 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0015 | 0.0015 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0015 | 0.0044 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0026 | 0.014 | 0.014 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0015 | 0.0044 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0209 | 0.0209 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0026 | 0.014 | 0.014 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0209 | 0.0621 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0026 | 0.014 | 0.0415 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0059 | 0.0363 | 0.1076 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0496 | 0.3368 | 1 |
Loa Loa (eye worm) | AGC/PDK1 protein kinase | 0.0059 | 0.0363 | 0.0363 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.014 | 0.014 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0496 | 0.3368 | 0.3368 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.1461 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0209 | 0.0117 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0121 | 0.0791 | 0.0791 |
Entamoeba histolytica | hypothetical protein | 0.0496 | 0.3368 | 0.3306 |
Entamoeba histolytica | 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein | 0.0496 | 0.3368 | 0.3306 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0496 | 0.3368 | 1 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0026 | 0.014 | 0.0415 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 0.0093 | 0.0093 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0496 | 0.3368 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | AGC family protein kinase | 0.0059 | 0.0363 | 0.0272 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0026 | 0.014 | 0.0373 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0014 | 0.0051 | 0.0051 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0026 | 0.014 | 0.0047 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0015 | 0.0015 |
Trypanosoma brucei | unspecified product | 0.0014 | 0.0051 | 0.0051 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0496 | 0.3368 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0209 | 0.0621 |
Mycobacterium ulcerans | hypothetical protein | 0.1461 | 1 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1461 | 1 | 1 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.1461 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0.0093 | 0.0276 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.1461 | 1 | 1 |
Trypanosoma brucei | unspecified product | 0.0014 | 0.0051 | 0.0051 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0015 | 0.0015 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.0496 | 0.3368 | 0.3368 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Echinococcus multilocularis | 3 phosphoinositide dependent protein kinase 1 | 0.0059 | 0.0363 | 0.1036 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0496 | 0.3368 | 0.3368 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.1461 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0093 | 0.0093 |
Plasmodium falciparum | flap endonuclease 1 | 0.0026 | 0.014 | 0.0415 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0496 | 0.3368 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 0.0093 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0209 | 0.0117 |
Echinococcus granulosus | 3-phosphoinositide-dependent protein kinase 1 | 0.0059 | 0.0363 | 0.1036 |
Loa Loa (eye worm) | hypothetical protein | 0.1461 | 1 | 1 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0496 | 0.3368 | 0.3368 |
Echinococcus multilocularis | dna polymerase eta | 0.002 | 0.0093 | 0.0232 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0496 | 0.3368 | 0.3306 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 0.0093 | 0.0232 |
Plasmodium vivax | polyprenol reductase, putative | 0.0496 | 0.3368 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Entamoeba histolytica | protein kinase, putative | 0.0059 | 0.0363 | 0.0272 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0015 | 0.0015 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0496 | 0.3368 | 0.3306 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1461 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0015 | 0.0015 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0496 | 0.3368 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0496 | 0.3368 | 1 |
Loa Loa (eye worm) | AGC/PDK1 protein kinase | 0.0059 | 0.0363 | 0.0363 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0093 | 0.0093 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0014 | 0.0051 | 0.0051 |
Schistosoma mansoni | smad | 0.0008 | 0.0015 | 0.0044 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0496 | 0.3368 | 0.3306 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0015 | 0.0044 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Brugia malayi | MH2 domain containing protein | 0.0121 | 0.0791 | 0.0791 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0014 | 0.0051 | 0.0051 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0015 | 0.0015 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1461 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0093 | 0.0093 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0015 | 0.0044 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 0.0093 | 0.0276 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0496 | 0.3368 | 0.3306 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0496 | 0.3368 | 0.3306 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0093 | 0.5 |
Brugia malayi | phosphoinositide-dependent protein kinase I | 0.0059 | 0.0363 | 0.0363 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0093 | 0.0232 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.014 | 0.014 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0209 | 0.0117 |
Loa Loa (eye worm) | hypothetical protein | 0.0496 | 0.3368 | 0.3368 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 0.0093 | 0.0276 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0015 | 0.0044 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0496 | 0.3368 | 0.3306 |
Entamoeba histolytica | trans-2,3-enoyl-CoA reductase, putative | 0.0496 | 0.3368 | 0.3306 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0093 | 0.0093 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0093 | 0.0093 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0496 | 0.3368 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0093 | 0.0093 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0209 | 0.0117 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0209 | 0.0579 |
Entamoeba histolytica | Flap nuclease, putative | 0.0026 | 0.014 | 0.0047 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | AGC family protein kinase | 0.0059 | 0.0363 | 0.0272 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0496 | 0.3368 | 1 |
Brugia malayi | Smad1 | 0.0008 | 0.0015 | 0.0015 |
Onchocerca volvulus | 0.0496 | 0.3368 | 0.5 | |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 0.0093 | 0.0232 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0093 | 0.0093 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0496 | 0.3368 | 0.3368 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0015 | 0.0015 |
Echinococcus granulosus | flap endonuclease 1 | 0.0026 | 0.014 | 0.0373 |
Schistosoma mansoni | flap endonuclease-1 | 0.0024 | 0.0122 | 0.0364 |
Schistosoma mansoni | DNA polymerase eta | 0.002 | 0.0093 | 0.0276 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0121 | 0.0791 | 0.0791 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.014 | 0.014 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0093 | 0.0232 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0093 | 0.0093 |
Trypanosoma brucei | unspecified product | 0.002 | 0.0093 | 0.0093 |
Leishmania major | DNA polymerase eta, putative | 0.002 | 0.0093 | 0.0093 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1461 | 1 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0496 | 0.3368 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.002 | 0.0093 | 0.0093 |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0.0363 | 0.0363 |
Echinococcus granulosus | dna polymerase eta | 0.002 | 0.0093 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0496 | 0.3368 | 0.3368 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0093 | 0.0093 |
Brugia malayi | Flap endonuclease-1 | 0.0026 | 0.014 | 0.014 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0209 | 0.0579 |
Trichomonas vaginalis | AGC family protein kinase | 0.0059 | 0.0363 | 0.0272 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.